Company intelligence / Profile preview

ApiJect Systems

Stamford, Connecticut, United States

Ownership: Private
Employees: ~36
Development stage: Other

Overview

ApiJect offers a scalable, advanced prefilled injection device platform—centered on Blow-Fill-Seal aseptic packaging—for single-dose injectables, with manufacturing capacity reaching billions of units annually; platform is FDA-recognized and used in partnership with major pharma/biotech companies for commercial and clinical supply.

Modalities: DevicePrefilled injectorBlow-Fill-Seal drug delivery platform
Industry: Consumable Medical Devices

Partnerships

U.S. Department of Health and Human Services (Project Jumpstart, COVID-19 vaccine prefilled syringes)U.S. Department of Defense (COVID-19 supply chain)Multiple unnamed pharmaceutical and biotech partners utilizing technology for fill-finish and delivery

Beyond the preview

Go deeper on ApiJect Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ApiJect Systems.

Explore the full profile